Indian pharmaceutical market is like a mirror, it reciprocates the similar image the way you look to it. My shelf is replete with those articles which say the future of Indian healthcare is as bright as a helium lamp. One day I decided to look it through a pessimist lenses and I found the same market which was touted to grow leaps and bounds is foundering like Indian hockey.
Statistics told me that 67% 0f the population (which amounts to 742 million) only contributes 17% to the market. A dried pipeline due to miniscule R & D investment coupled with improper distribution network make the market less accessible. Branded generics and Generic generics rule the market and no concerted efforts being made to improve the care management and treatment cost. Above all any Tom, Dick and Harry’s mother in low can come up with any combinations –rational & irrational only criteria which should meet is return of investment. Non pragmatic cost regulations which control the output without even poking at the inputs helping the investors finding their feet but in some other countries.
Hollywood and Indian pharma has a strange similarity. Both are in to a lot of remaking (the old ones). Thus innovation here is limited to mere shuffling of combinations and older molecules which not replace any therapy but add to it. Compulsory licensing bogy we brandish no will keep the investors stay away.
The rule is very simple, if you want it to be the next big thing, please treat it like the next big thing and if you see no other way but to treat it like this, don’t foresee a brighter future.
No comments:
Post a Comment